Follow
Rosa Terracciano
Title
Cited by
Cited by
Year
Nanotechnologies for biomolecular detection and medical diagnostics
MMC Cheng, G Cuda, YL Bunimovich, M Gaspari, JR Heath, HD Hill, ...
Current opinion in chemical biology 10 (1), 11-19, 2006
6282006
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma
G Pelaia, A Vatrella, MT Busceti, L Gallelli, C Calabrese, R Terracciano, ...
Mediators of inflammation 2015, 2015
2762015
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A†…
L Gallelli, O Galasso, D Falcone, S Southworth, M Greco, V Ventura, ...
Osteoarthritis and cartilage 21 (9), 1400-1408, 2013
1662013
Benralizumab: from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma
C Pelaia, C Calabrese, A Vatrella, MT Busceti, E Garofalo, N Lombardo, ...
BioMed research international 2018, 2018
1342018
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano, F de Blasio, A Vatrella, G Pelaia
Therapeutic advances in respiratory disease 12, 1753466618810192, 2018
1312018
Selective binding and enrichment for low‐molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles
R Terracciano, M Gaspari, F Testa, L Pasqua, P Tagliaferri, MMC Cheng, ...
Proteomics 6 (11), 3243-3250, 2006
1022006
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
C Pelaia, A Vatrella, MT Busceti, L Gallelli, R Terracciano, R Savino, ...
Drug design, development and therapy, 3137-3144, 2017
1002017
Molecular targets for biological therapies of severe asthma
C Pelaia, C Crimi, A Vatrella, C Tinello, R Terracciano, G Pelaia
Frontiers in immunology 11, 603312, 2020
912020
Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma
M Gaspari, M Ming-Cheng Cheng, R Terracciano, X Liu, AJ Nijdam, ...
Journal of proteome research 5 (5), 1261-1266, 2006
912006
The proteomics big challenge for biomarkers and new drug-targets discovery
R Savino, S Paduano, M PreianÚ, R Terracciano
International journal of molecular sciences 13 (11), 13926-13948, 2012
902012
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non‐small lung cancer cells
G Pelaia, L Gallelli, T Renda, D Fratto, D Falcone, M Caraglia, MT Busceti, ...
Cell proliferation 45 (6), 557-565, 2012
862012
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: results of a single-centre observational†…
C Pelaia, MT Busceti, S Solinas, R Terracciano, G Pelaia
Pulmonary pharmacology & therapeutics 53, 1-5, 2018
712018
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy
C Pelaia, A Vatrella, A Bruni, R Terracciano, G Pelaia
Drug design, development and therapy, 619-628, 2018
672018
Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells
C Celia, N Malara, R Terracciano, D Cosco, D Paolino, M Fresta, ...
Nanomedicine: Nanotechnology, Biology and Medicine 4 (2), 155-166, 2008
642008
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: assessment of blood eosinophils, symptom control, lung function and oral†…
C Pelaia, MT Busceti, A Vatrella, GF Rago, C Crimi, R Terracciano, ...
Pulmonary Pharmacology & Therapeutics 58, 101830, 2019
632019
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI‐TOF MS for non‐invasive biomarker discovery of chronic inflammatory lung diseases
R Terracciano, M PreianÚ, GP Palladino, GE Carpagnano, MPF Barbaro, ...
Proteomics 11 (16), 3402-3414, 2011
632011
Role of biologics in severe eosinophilic asthma–focus on reslizumab
G Pelaia, A Vatrella, MT Busceti, L Gallelli, M PreianÚ, N Lombardo, ...
Therapeutics and Clinical Risk Management, 1075-1082, 2016
602016
Asthma and COPD proteomics: current approaches and future directions
R Terracciano, G Pelaia, M PreianÚ, R Savino
PROTEOMICS–Clinical Applications 9 (1-2), 203-220, 2015
532015
Application of proteomics and peptidomics to COPD
G Pelaia, R Terracciano, A Vatrella, L Gallelli, MT Busceti, C Calabrese, ...
BioMed research international 2014, 2014
512014
Lycopene and bone: An in vitro investigation and a pilot prospective clinical study
C Russo, Y Ferro, S Maurotti, MA Salvati, E Mazza, R Pujia, R Terracciano, ...
Journal of translational medicine 18, 1-11, 2020
502020
The system can't perform the operation now. Try again later.
Articles 1–20